Clinical Trial Update: Anti-PD-1/PD-L1 Antibodies Plus Gemcitabine and Cisplatin for Advanced CCA

View source ↗

Summary

A clinical trial is evaluating anti-PD-1/PD-L1 antibodies in combination with gemcitabine and cisplatin for advanced cholangiocarcinoma, and is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• Anti-PD-1/PD-L1 antibody
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Cholangiocarcinoma | Status: RECRUITING